1. Home
  2. QBTS vs TVGN Comparison

QBTS vs TVGN Comparison

Compare QBTS & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

SELL

Current Price

$8.68

Market Cap

6.0B

Sector

Technology

ML Signal

SELL

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.02

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
QBTS
TVGN
Founded
1999
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
21.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
QBTS
TVGN
Price
$8.68
$6.02
Analyst Decision
Strong Buy
Analyst Count
17
0
Target Price
★ $23.72
N/A
AVG Volume (30 Days)
★ 11.8M
8.0K
Earning Date
11-10-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$52.13
N/A
Revenue Next Year
$102.94
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.48
$0.14
52 Week High
$32.39
$24.91

Technical Indicators

Market Signals
Indicator
QBTS
TVGN
Relative Strength Index (RSI) 31.22 48.17
Support Level $8.48 $5.01
Resistance Level $12.03 $7.55
Average True Range (ATR) 0.87 0.48
MACD 0.03 0.03
Stochastic Oscillator 5.53 51.00

Price Performance

Historical Comparison
QBTS
TVGN

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: